Cargando…
Targeting the Neurokinin Receptor 1 with Aprepitant: A Novel Antipruritic Strategy
BACKGROUND: Chronic pruritus is a global clinical problem with a high impact on the quality of life and lack of specific therapies. It is an excruciating and frequent symptom of e.g. uncurable renal, liver and skin diseases which often does not respond to conventional treatment with e.g. antihistami...
Autores principales: | Ständer, Sonja, Siepmann, Dorothee, Herrgott, Ilka, Sunderkötter, Cord, Luger, Thomas A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2881044/ https://www.ncbi.nlm.nih.gov/pubmed/20532044 http://dx.doi.org/10.1371/journal.pone.0010968 |
Ejemplares similares
-
The Neuromodulatory Effect of Antipruritic Treatment of Chronic Prurigo
por: Zeidler, Claudia, et al.
Publicado: (2019) -
The Neurokinin-1 Receptor Antagonist Aprepitant: An Intelligent Bullet against Cancer?
por: Muñoz, Miguel, et al.
Publicado: (2020) -
Aprepitant inhibits the progression of esophageal squamous cancer by blocking the truncated neurokinin‑1 receptor
por: Zheng, Yang, et al.
Publicado: (2023) -
GPCR large-amplitude dynamics by (19)F-NMR of aprepitant bound to the neurokinin 1 receptor
por: Pan, Benxun, et al.
Publicado: (2022) -
The Repurposing of Non-Peptide Neurokinin-1 Receptor Antagonists as Antitumor Drugs: An Urgent Challenge for Aprepitant
por: Coveñas, Rafael, et al.
Publicado: (2023)